メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
岡山大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
設備
活動
プレス/メディア
受賞
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
檜垣 文代
助教
,
岡山大学病院
h-index
278
被引用数
5
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2006
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(16)
類似のプロファイル
(6)
フィンガープリント
Fumiyo Higakiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Computer Assisted Tomography
100%
Positron Emission Tomography-Computed Tomography
74%
Percutaneous Endoscopic Gastrostomy
74%
Adenocarcinoma
37%
Esophagostomy
37%
Radiofrequency Ablation
37%
Squamous Cell Carcinoma
37%
Rhinocerebral Mucormycosis
37%
Congenital Malformation
37%
Pulmonary Artery
37%
Hernia
37%
Cholesteatoma
37%
Radiation Therapy
37%
Predictive Factor
37%
Stapes
37%
Leg
37%
Lung Tumor
37%
Lung Cancer
37%
Ganglioglioma
37%
Tympanosclerosis
37%
Gastric Lymphoma
37%
Helicobacter Pylori
37%
Fluorodeoxyglucose
37%
Allogeneic Hematopoietic Stem Cell Transplantation
37%
Hypersensitivity Pneumonitis
37%
Overall Survival
28%
Symptom
28%
Non Small Cell Lung Cancer
25%
Small Cell Lung Cancer
25%
Neoplasm
21%
Gastrectomy
18%
Odds Ratio
18%
Prognostic Factor
18%
Logistic Regression Analysis
18%
Hematopoietic Stem Cell Transplantation
18%
Tumor Progression
12%
Kruskal Wallis Test
12%
Intensity Modulated Radiation Therapy
12%
Radiation Injury
12%
Pelvic Magnetic Resonance Imaging
12%
Hormone Therapy
12%
Prostate Cancer
12%
Cancer Types
12%
Clinical Stage
12%
Pelvis
12%
Provocation Test
12%
Contralateral
9%
Brainstem
9%
Thalamus
9%
Sinusitis
9%
Keyphrases
Neuromelanin
37%
Histological Subtypes
37%
Rhinocerebral mucormycosis
37%
Risk Factors
37%
Percutaneous Endoscopic Gastrostomy
37%
Cervical Esophagostomy
37%
H3 G34-mutant
37%
Data Review
37%
Diffuse Hemispheric Glioma
37%
Adenocarcinoma
37%
Dementia
37%
Hydrogel Spacer
37%
Primary Lung Cancer
37%
DuraGen
37%
Squamous Cell Carcinoma (SqCC)
37%
FDG PET-CT
37%
Remission
37%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
37%
Hypersensitivity Pneumonitis
37%
Pars Compacta
28%
Small Cell Lung Carcinoma
25%
Attenuation
25%
Unenhanced
25%
Phase Dynamics
25%
Non-small Cell Lung Cancer (NSCLC)
25%
Hounsfield Units
25%
2-phase
25%
Odds Ratio
18%
Confidence Interval
18%
Hematopoietic Stem Cell Transplantation
18%
Patients with Dementia
14%
Initiation Time
12%
Enhancement Value
12%
Dynamic Scan
12%
Kruskal-Wallis Test
12%
Dynamic Computed Tomography
12%
Lung Computed Tomography
12%
Region of Interest
12%
Cancer Types
12%
Attenuation Coefficient
12%
Enhancement Pattern
12%
Lung Cancer Patients
12%
Inhalation Challenge
12%
Mucosal Thickening
9%
Opportunistic Fungal Infections
9%
Survival Rate
9%
Intranuclear Inclusion Bodies
9%
Variable Clinical Manifestation
9%
SARA Score
9%
Diffusion-weighed Imaging
9%
Neuroscience
Neuromelanin
74%
Magnetic Resonance Imaging
37%
Corticobasal Degeneration
37%
Frontal Lobe
37%
Basal Ganglia
37%
Serum Albumin
37%
Positron Emission Tomography-Computed Tomography
37%
Progressive Supranuclear Palsy
37%
Contrast Medium
37%
Ataxia
37%
Multiple System Atrophy
37%
Cerebrum
37%
Brainstem
37%
Thalamus
37%
Corpus Callosum
37%
Tympanosclerosis
37%
Computed Tomography
28%
Parkinson's Disease
23%
Survival Analysis
18%
Magnetic Resonance Imaging
18%
Spinocerebellar Ataxia
14%
Neurodegenerative Disorder
9%
Hyalin
9%
Peripheral Neuropathy
9%
Dysautonomia
9%
